Literature DB >> 14615459

Bisphosphanates and oral cavity avascular bone necrosis.

Cesar A Migliorati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14615459     DOI： 10.1200/JCO.2003.99.132

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  72 in total

1.  Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws.

Authors:  Thomas Mücke; Janett Koschinski; Herbert Deppe; Stefan Wagenpfeil; Christoph Pautke; David A Mitchell; Klaus-Dietrich Wolff; Frank Hölzle
Journal:  J Cancer Res Clin Oncol       Date:  2010-10-07       Impact factor: 4.553

Review 2.  A systematic review of bisphosphonate osteonecrosis (BON) in cancer.

Authors:  Cesar Augusto Migliorati; Sook-Bin Woo; Ian Hewson; Andrei Barasch; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-04-22       Impact factor: 3.603

Review 3.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

4.  Osteonecrosis of maxilla secondary to bisphosphonate therapy: a case report.

Authors:  Trupti Kolur; Sanjiv C Nair; Balasubramanya Kumar
Journal:  J Maxillofac Oral Surg       Date:  2011-12-21

5.  Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma.

Authors:  Kazuho Shimura; Chihiro Shimazaki; Kyoko Taniguchi; Sonoko Akamatsu; Masashi Okamoto; Ryo Uchida; Ken-ichi Nomura; Tohru Inaba; Shigeo Horiike; Narisato Kanamura; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

6.  Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis.

Authors:  Christian Walter; Knut A Grötz; Martin Kunkel; Bilal Al-Nawas
Journal:  Support Care Cancer       Date:  2006-08-29       Impact factor: 3.603

7.  [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].

Authors:  S Hoefert; H Eufinger
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07

8.  Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.

Authors:  Salvatore Ruggiero; Julie Gralow; Robert E Marx; Ana O Hoff; Mark M Schubert; Joseph M Huryn; Bela Toth; Kathryn Damato; Vicente Valero
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

Review 9.  Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.

Authors:  Sven Otto; Christoph Pautke; Sigurd Hafner; Ronny Hesse; Lea Franziska Reichardt; Gerson Mast; Michael Ehrenfeld; Carl-Peter Cornelius
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-05-31

Review 10.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.